Grow your business safely with EUROFINS DEV BIOPHARMA FRANCE 3

All the information you need about EUROFINS DEV BIOPHARMA FRANCE 3 to develop and secure your business in France

E HOME > CORPORATES > EUROFINS DEV BIOPHARMA FRANCE 3 > BALANCE SHEET ( 2020-11-25)

THE LIST OF BALANCE SHEET : EUROFINS DEV BIOPHARMA FRANCE 3

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-06-22 Public 2021-12-31 Complete
2021-06-22 Public 2020-12-31 Complete
2020-11-25 Public 2019-12-31 Complete
2019-05-22 Public 2018-12-31 Complete
2018-06-11 Public 2017-12-31 Complete
NameEUROFINS PRODUCT TESTING 2 FRANCE HOLDING
Siren833456783
Closing2019-12-31
Registry code 4401
Registration number 19421
Management number2017B03194
Activity code 7120B
Closing date n-12018-12-31
Duration Fiscal year 12
Duration Fiscal year n-100
Filing date2020-11-25
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address44300 NANTES
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BJ TOTAL (I) 12 210 157.00 12 210 157.00 12 210 157.00
BZ Other receivables 600 536.00 600 536.00 600 536.00
CF Cash and cash equivalents 17 120.00 17 120.00 17 120.00
CJ TOTAL (II) 617 656.00 617 656.00 617 656.00
CO Grand total (0 to V) 12 827 813.00 12 827 813.00 12 827 813.00
CU Other investments 12 210 157.00 12 210 157.00 12 210 157.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 5 205 000.00 5 205 000.00 5 205 000.00
DH Retained earnings -71 044.00 -1 300.00 -71 044.00
DI RESULTS FOR THE YEAR (Profit or Loss) 268 669.00 -69 743.00 268 669.00
DL TOTAL (I) 5 402 625.00 5 133 957.00 5 402 625.00
DX Trade payables and related accounts 2 659.00 1 610.00 2 659.00
EA Other liabilities 7 422 529.00 7 160 632.00 7 422 529.00
EC TOTAL (IV) 7 425 188.00 7 162 242.00 7 425 188.00
EE Grand total (I to V) 12 827 813.00 12 296 199.00 12 827 813.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FW Other purchases and external expenses 45 118.00
FX Taxes, duties, and similar payments 489.00
GF Total Operating Expenses (II) 45 607.00
GG - OPERATING RESULT (I - II) -45 607.00
GJ Financial income from other securities and fixed asset receivables 569 669.00
GP Total financial income (V) 569 669.00
GR Interest and similar expenses 255 393.00
GU Total financial expenses (VI) 255 393.00
GV - FINANCIAL INCOME (V - VI) 314 276.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 268 669.00
4 - Income statement (continued)Amount year NAmount year N-1
HL TOTAL REVENUE (I + III + V + VII) 569 669.00 569 669.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 301 000.00 69 743.00 301 000.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 268 669.00 -69 743.00 268 669.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 11 967 094.00 243 063.00 11 967 094.00
I3 DECREASES Total Financial Fixed Assets 12 210 157.00
I4 DECREASES Grand Total 12 210 157.00
LQ ACQUISITIONS Total Financial Fixed Assets 11 967 094.00 243 063.00 11 967 094.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 2 659.00 2 659.00 2 659.00
VC Group and associates 600 000.00 600 000.00 600 000.00
VI Group and Associates 7 422 529.00 64 908.00 7 357 621.00 7 422 529.00
VR Miscellaneous debtors (including receivables related to repo transactions) 536.00 536.00 536.00
VT TOTAL – STATEMENT OF RECEIVABLES 600 536.00 600 536.00 600 536.00
VY TOTAL – STATEMENT OF LIABILITIES 7 425 188.00 67 567.00 7 357 621.00 7 425 188.00

all companies in France

Complete and comprehensive database.